Track topics on Twitter Track topics that are important to you
BOSTON, June 4, 2015 (GLOBE NEWSWIRE) -- LogMeIn, Inc. (Nasdaq:LOGM), the company behind the popular join.me meeting and collaboration app, today disclosed the acquisition of San Francisco-based Zamurai Corporation, a pioneer in mobile collaboration and whiteboarding. Zamurai's highly acclaimed mobile whiteboard has been integrated into join.me as part of a new mobile push and major refresh of join.me's iPhone, iPad and Apple Watch apps. It will now be offered exclusively via join.me.
The deal, which closed in late 2014, was LogMeIn's second recent acquisition of a San Francisco start-up. The entire Zamurai team is staying on as a part of the transaction, with the co-founders taking leadership roles on join.me's marketing and product organizations.
Founded in 2013, Zamurai builds mobile-first real-time visual collaboration solutions to help professionals capture and share their ideas and conversations. The company's mobile whiteboarding app was featured as a Best New Productivity App in the App Store. The Zamurai Mobile Whiteboard re-approached the whiteboard experience for mobile including a powerful library of images, lines, shapes with a state of the art drawing tool all on an infinite canvas.
"Mobile innovation is a key focus for join.me. And we believe that a true mobile-first approach means embracing the unique benefits of mobile to boost collaboration, as opposed to trying to duplicate desktop or in-person experiences on a mobile device," said Bill Wagner, president and COO of LogMeIn, makers of join.me. "With the acquisition of Zamurai team, we gain both a team and product that can help us rapidly accelerate join.me's mobile-first innovation – innovation aimed squarely at addressing the new realities of today's inherently mobile workforce."
Zamurai was named a "Hot Vendor in Content Authoring and Collaboration, 2014" by Aragon Research and earned several industry accolades, including being a Best App Finalist (two categories Collaboration and Productivity) in the Tabby Awards; Best Business App Finalist in the Appy Awards; and a NetworkWorld 'Top 20 Productivity App' in 2014, among others.
"Both join.me and Zamurai recognize that how people work has changed. We meet and collaborate in real time and more often than not, we interact online. And we were both passionate about the simplicity of the experience for our customers," said Michael Parker, CEO and co-founder of Zamurai, now VP of Marketing for join.me. "The fact is Zamurai was actually a join.me customer. We used it everyday, so it was obvious how complementary we were together."
Zamurai is building the mobile-first real time visual collaboration solution for today's business letting professionals capture and share their ideas and conversations on any device – phone, tablet, or desktop. Founded in 2013, Zamurai's mission is to enable businesses to capture ideas and discussions so they can be accessed anywhere, anytime. For more information, visit http://zamurai.com.
About LogMeIn, Inc.
LogMeIn, Inc. (Nasdaq:LOGM) simplifies how people connect to each other and the world around them. With millions of users worldwide, our cloud-based solutions make it possible for people and companies to connect and engage with their workplace, colleagues, customers and products anywhere, anytime. LogMeIn is headquartered in Boston with offices in Bangalore, Budapest, Dublin, London, San Francisco and Sydney.
CONTACT: Craig VerColen LogMeIn +1-781-897-0696 email@example.comNEXT ARTICLE
Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...
Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...